Focus: CENTOGENE is a German biotechnology company specializing in genetic testing and biomarker discovery for rare diseases, operating a global diagnostics and research platform. The company has recently expanded into Asia (Taiwan HQ) and the Middle East (Abu Dhabi laboratory ownership), positioning itself as an international rare-disease diagnostics leader.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Stable — net -3 jobs in 30d
0 added, 3 removed. Backfill posture.
CENTOGENE is a specialized rare-disease diagnostics play with genuine international growth tailwinds, but limited headcount churn and early-stage pipeline depth suggest it suits researchers seeking niche expertise over those prioritizing rapid advancement or near-term approvals.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for CENTOGENE
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from CENTOGENE's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Centogene takes ownership in Pearl Medical Analysis Laboratory in Abu Dhabi - Zawya
Centogene takes ownership in Pearl Medical Analysis Laboratory in Abu Dhabi Zawya
If You Invested $1,000 in Centogene N.V. (CNTG) - Stock Titan
If You Invested $1,000 in Centogene N.V. (CNTG) Stock Titan
German Rare Disease Diagnostics Firm CENTOGENE Moves Closer to Asia’s Frontlines With Taiwan HQ - geneonline.com
German Rare Disease Diagnostics Firm CENTOGENE Moves Closer to Asia’s Frontlines With Taiwan HQ geneonline.com
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo